Nexus Pharmaceuticals Announces the Launch of Cyclophosphamide Injection
Nexus Pharmaceuticals, LLC is pleased to announce the commercial launch of Cyclophosphamide Injection, now available in ready-to-dilute 2.5 mL and 5 mL fill multiple-dose vials. As the first AP-rated generic to Dr. Reddy’s, this product reflects our ongoing commitment to expanding access to high-quality, critical care medications that patients and providers depend on. Cyclophosphamide Injection […]
Nexus Pharmaceuticals Announces Launch of Tacrolimus Injection
We’re proud to share the news of our latest product launch: Tacrolimus Injection, USP 5 mg/mL, now available in a single-dose vial format. This critical immunosuppressant is indicated for the prevention of organ rejection in liver and kidney transplant patients, offering healthcare providers a new, cost-effective option in a convenient presentation. This launch represents another step […]
Nexus Pharmaceuticals Launches Baclofen Injection Refill Kit
Nexus Pharmaceuticals introduces the Baclofen Injection Refill Kit, the only vial-based option on the market, offering a convenient solution for healthcare providers managing patients with long-term severe spasticity.
Nexus Pharmaceuticals Launches Fluorescein 2 mL
Nexus Pharmaceuticals introduces a 2 mL vial of Fluorescein Injection, USP 25%, enhancing diagnostic options for eye care professionals and reinforcing its commitment to specialty injectable solutions.
Nexus Pharmaceuticals Launches Tranexamic Acid
Nexus Pharmaceuticals announces the launch of Tranexamic Acid Injection, an antifibrinolytic agent essential for surgical bleeding control, now available in cartons of 10 bags through wholesalers.